Uptake of adjuvant breast cancer treatments recommended by multi ‐disciplinary meetings
ConclusionsUptake of MDM‐recommended treatments is high. There is a minority of patients in whom MDM recommendations are not followed, highlighting that there are extra steps between recommendations at an MDM and decisions with patients. More attention to this issue is appropriate, and the reasons for non‐concordance warrant further study.
Source: ANZ Journal of Surgery - Category: Surgery Authors: Melinda Pattanasri, Kenneth Elder, Carolyn Nickson, Samuel Cooke, Dorothy Machalek, Allison Rose, Arlene Mou, John P. Collins, Allan Park, Richard De Boer, Claire Phillips, Vicki Pridmore, Helen Farrugia, G. Bruce Mann Tags: Original Article Source Type: research
More News: Australia Health | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | Chemotherapy | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Endocrine Therapy | Study | Surgery | Women